Golimumab
Golimumab (CNTO-148) is a potent humanized anti-TNFα IgG1κ monoclonal antibody with anti-inflammatory and anticancer activity. It inhibits the production of IL-6 and IL-1β, induces apoptosis, and can be used to prevent inflammation and destruction of cartilage or bone. This makes Golimumab valuable for studying rheumatoid arthritis and cancer.
Product Specifications
CAS Number
476181-74-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
146.93KD
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
TNF
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
sc-343115A 5 g
[2-Nitro-4- (pyrrolidine-1-sulfonyl) -phenyl]-hydrazine
Sign In for Pricing
View Details CSB-EP001154BO-01 20 µg
Recombinant Bovine Acetylcholinesterase (ACHE)
Sign In for Pricing
View Details 
CSB-EP001154BO-02 100 µg
Recombinant Bovine Acetylcholinesterase (ACHE)
Sign In for Pricing
View Details